Detalhe da pesquisa
1.
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101).
Cancer Sci
; 115(4): 1273-1282, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287788
2.
Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer.
Cancer Control
; 28: 1073274820985790, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33733906
3.
A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).
Int J Clin Oncol
; 23(6): 1060-1069, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027464
4.
Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
JAMA Oncol
; 10(4): 439-447, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451530
5.
Anti-CTLA-4 Antibody Might Be Effective Against Non-small Cell Lung Cancer With Large Size Tumor.
Anticancer Res
; 43(9): 4155-4160, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648314
6.
Real-world data on the efficacy and safety of immune-checkpoint inhibitors in elderly patients with non-small cell lung cancer.
Cancer Med
; 12(10): 11525-11541, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999734
7.
First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002).
Sci Rep
; 11(1): 23140, 2021 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848786
8.
Prognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902).
Lung Cancer
; 156: 12-19, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872943
9.
Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer.
Oncoimmunology
; 10(1): 1971430, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552823
10.
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).
Lung Cancer
; 153: 134-142, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33508526
11.
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival.
Heliyon
; 6(7): e04439, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32685741
12.
Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.
J Immunother Cancer
; 7(1): 97, 2019 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944043
13.
Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-ßRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
Oncotarget
; 8(24): 39711-39726, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28055980
14.
Expression of Notch1 and Numb in small cell lung cancer.
Oncotarget
; 8(6): 10348-10358, 2017 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28060745
15.
Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A).
Lung Cancer
; 90(3): 548-53, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604032
16.
Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.
Cancer Chemother Pharmacol
; 74(6): 1149-57, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294632